Uncategorized
VIDEO: Presbyopia-correcting eye drop formulation progresses in clinical trials
CHICAGO — At the Ophthalmology Innovation Summit at AAO, Elad Kedar, CEO of Orasis Pharmaceuticals, discusses the progress of the company’s eye drop CSF-1 for the treatment of presbyopia.